<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-HKL4TSXW</identifier><date>2019</date><creator>Gabrovec, Branko</creator><creator>Jelenc, Marjetka</creator><relation>documents/doc/H/URN_NBN_SI_doc-HKL4TSXW_001.pdf</relation><relation>documents/doc/H/URN_NBN_SI_doc-HKL4TSXW_001.txt</relation><format format_type="issue">1</format><format format_type="volume">6</format><format format_type="type">article</format><format format_type="extent">str. 54-68</format><identifier identifier_type="ISSN">2350-3610</identifier><identifier identifier_type="COBISSID">514887031</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-HKL4TSXW</identifier><language>eng</language><publisher>Univerza v Novem mestu, Fakulteta za zdravstvene vede</publisher><source>Revija za zdravstvene vede</source><rights>InC</rights><subject language_type_id="slv">Evropa</subject><subject language_type_id="slv">krhkost</subject><subject language_type_id="slv">polifarmacija</subject><subject language_type_id="slv">predpisovanje zdravil</subject><subject language_type_id="slv">smernice</subject><subject language_type_id="slv">starejši ljudje</subject><title>evidence from ADVANTAGE joint action</title><title>Strategies for improving polypharmacy in the elderly population in Europe</title></Record>